| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1915919 | Journal of the Neurological Sciences | 2007 | 4 Pages |
Abstract
Patients with small-cell lung cancer (SCLC) have a poor prognosis with a three year survival rate of 4%. Our report concerns three patients with histologically proven SCLC and anti-Hu associated paraneoplastic neurological syndrome who have survived for 11 in two cases and 16 years respectively. The patients showed progressive deterioration which was only partly beneficially modulated by steroid therapy or tumor treatment, even in the cases with complete tumor remission.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
A. Poepel, S. Jarius, L.C. Heukamp, H. Urbach, C.E. Elger, C.G. Bien, R. Voltz,